VedaCheck a rash

Skin sensitivity and burning on Ozempic, Wegovy, Mounjaro and Zepbound: what it means and what to do

By Veda Editorial TeamEdited by Uladzislau YasinskiUpdated 11 sourcesHow we write

Not affiliated with or endorsed by Novo Nordisk or Eli Lilly.

Your shirt feels like sandpaper. The shower stings. You look at your skin and it looks completely normal.

This page covers what the FDA labels and published reports say about burning or sensitive skin on GLP-1 medicines, what else it can be, and how to walk into your appointment with something specific.

Quick answer: This is a recognized effect. The Wegovy, Zepbound, Mounjaro and Ozempic labels list dysesthesia, meaning altered skin sensations such as burning, tingling, pain of the skin and sensitive skin, and the Wegovy label says it increased with higher dosage. Usually there is nothing to see, so there is nothing to photograph. The most useful steps are a symptom diary, a conversation with the prescriber, and having other causes ruled out. Published cases range from clearing by itself to clearing after the prescriber changed or ended treatment, which is why that decision belongs to the prescriber. A few signs need a doctor the same day, or 911.

Illustration of a soft cotton shirt sleeve resting on a calm arm outline with a few teal sparkle marks, and a notebook with a pencil beside it
Skin can hurt to the touch and look completely normal. Writing down what you feel makes the conversation with your doctor specific.

Get help first: when burning or painful skin is not a simple side effect

  • Emergency (call 911 or go to the ER): swelling of the face, lips, tongue or throat, trouble breathing or swallowing, fainting or feeling dizzy, a very rapid heartbeat, or a severe rash or itching. These are the serious allergic reaction signs in the Medication Guides, which say to get medical help right away. Also: one side of the face drooping, sudden weakness or numbness on one side of the body, or sudden trouble speaking. Those are signs of a stroke, so do not wait. Tell the emergency team which medicine you use.
  • Same-day doctor (call the prescriber, an urgent care clinic or a nurse line today): burning, tingling or sharp pain in a band or patch on one side of the body, with or without blisters. That pattern can be the start of shingles, which can cause a tingling or painful feeling in an area of skin a few days before the rash appears. NHS guidance says shingles medicine works best when started within 3 days of the rash appearing, so do not wait. Also today: skin that is hot, red, swollen and painful, or skin pain with a fever.
  • Soon (tell the prescriber this week): burning or sensitivity that keeps you from sleeping, dressing or working, that is spreading to new areas, or that is getting worse.

What skin sensitivity on a GLP-1 medicine means

You are not imagining it. Two medical words cover it.

Dysesthesia is the word on the FDA labels. It means altered skin sensations, and the Wegovy label's list includes paresthesia (tingling or pins and needles), pain of the skin, sensitive skin and a burning skin sensation.

Allodynia is pain from something that does not normally hurt: extreme sensitivity to touch or mild temperature change (Chakrabarti and colleagues, 2026). In daily life that can be light touch, clothing, a shower or a breeze.

The skin usually looks normal, with no rash and no redness, so a photo cannot show the problem. That is also why people so often feel dismissed. It is a documented sensation, not a sign of anything imagined.

What the FDA labels say

MedicineActive ingredientWhat the FDA label reports
WegovysemaglutideDysesthesia is listed among its most common adverse reactions (5% or more). In weight-loss trials at the standard dose, 2% on the drug versus 1% on placebo. In trials of a higher dose, 22% versus 6% on the standard dose and 0.3% on placebo. In a trial of the Wegovy tablet, 5% versus none on placebo.
ZepboundtirzepatideTwo pooled weight-loss trials: 0.2%, 0.2% and 0.4% across its three dose groups versus 0.1% on placebo.
MounjarotirzepatidePooled placebo-controlled trials in adults: 0.4% in each of its three dose groups versus none on placebo. In a cardiovascular outcomes trial in adults with type 2 diabetes: 0.7%.
OzempicsemaglutideListed among reports after approval, from a population of unknown size, so the label says frequency cannot be reliably estimated.

These come from different trials and different word lists. The Wegovy label counts paresthesia, hyperesthesia, burning sensation, allodynia, dysesthesia, skin burning sensation, pain of skin and sensitive skin together, a wider list than Zepbound's. Do not read the table as a ranking.

The Wegovy label also says the incidence of dysesthesia increased with increasing dosage and drug levels in the blood.

What case reports and reporting data add

Trials count events. Case reports and safety databases describe what people went through. None of them can give odds.

  • A 2026 analysis of the WHO global safety-report database found signals for hyperesthesia with semaglutide and tirzepatide, and for dysesthesia and burning sensation with semaglutide. It appeared dose-dependent, and skin burning was a distinctive form (Laroche and colleagues). In many of the reports treatment had been ended and outcomes were then favourable, and some cases returned when treatment was resumed.
  • A 2025 case series of 4 people on semaglutide for obesity described allodynia that followed a step up in treatment. Two people ended treatment and both recovered. Two continued, and one of them recovered after 4 months. The authors say it is not known whether this is a class effect or whether it consistently resolves (Stark and colleagues).
  • A 2025 case report described allodynia and dysesthesia on semaglutide and on tirzepatide, and notes it may resolve spontaneously after several weeks (Ahern).
  • A 2026 case series of 2 people on tirzepatide described moderate to severe allodynia that followed a step up in treatment (Chakrabarti and colleagues).
  • A 2026 review of skin and injection site reactions lists dysesthesias among the events reported to the FDA, and says most reactions were mild to moderate (Elgindi and Petronic-Rosic).

In these papers, outcomes ranged from clearing by itself to clearing after the prescriber changed or ended treatment. The Wegovy label's dysesthesia section also describes what clinicians did in its trials and how people recovered. All of that is for the prescriber to weigh. It is not something to copy by yourself, so do not change anything about your medicine on your own.

Is it the medicine? Other things that make skin burn or hurt

The timeline is your best clue. In the case reports, the symptoms followed a step up in treatment. A doctor will also want to rule out other common causes:

  • Shingles. The first signs can be a tingling or painful feeling in an area of skin, a headache or feeling unwell. A rash usually follows a few days later as blotches on one side of the body that turn into itchy blisters. In rare cases there is pain without a rash (NHS).
  • Nerve damage (peripheral neuropathy). Numbness and tingling in the hands or feet, and burning, stabbing or shooting pain. Diabetes is the most common cause in the UK, and other causes include nerve injury, a viral infection such as shingles, and a side effect of certain medicines (NHS). This matters because many people take Ozempic and Mounjaro for type 2 diabetes.
  • A visible skin problem such as sunburn, an eczema flare or an infection.

A doctor sorts these out with your history, an exam and sometimes tests. Do not self-diagnose from the internet.

A symptom diary to bring to your appointment

It makes a vague complaint specific, and it shows whether the sensation follows your injection day or a change in treatment. Copy this into a notebook or a notes app:

DateWhere on the bodyWhat it feels likeWhat sets it offIntensity (0 to 10)Sleep or daily life affected

Also write down:

  • The date you started the medicine and the date of every change in your treatment.
  • Anything else new in the same weeks: other medicines, supplements, skin products.
  • Photos of any visible skin change, if a rash or redness appears.

What to ask your prescriber

Bring the diary and ask:

  • Is this a known effect of my medicine?
  • Does the timing fit what is known about it?
  • What else could it be, and which tests make sense for me?
  • What should I do if it gets worse, and who do I call?
  • When should I check back with you?
  • What, if anything, should change in my treatment?

That last question is the prescriber's call, and so is every other decision about the medicine. Talk to a doctor or pharmacist before taking any pain reliever or putting any cream on the skin, especially in pregnancy, while breastfeeding, on other medicines, or with kidney or liver disease.

What you can do while you wait

We found no treatment tested for GLP-1 skin sensitivity, so nothing here is a treatment. These only make days easier, and there is no proof behind them:

  • Soft, loose clothing.
  • Lukewarm showers instead of hot ones, since allodynia can include sensitivity to temperature change.
  • Pat skin dry instead of rubbing.
  • Avoid scratching or picking.

Keep filling in the diary every day.

Will it go away?

Nobody can give you a date. In the Wegovy label's higher-dose trials, 288 people had dysesthesia and 18% of them had not reported recovering by the end of the trial, which means most had. Case reports describe clearing within weeks to months, some without any change to treatment, and others after treatment ended.

Whether to change or end treatment is the prescriber's decision, and this page cannot make it for you.

Can you see redness, a rash or hives as well as the burning? Add a photo, and the photo check describes what it sees. It is a description, not a diagnosis.

Tap to add a photo of the rashAI describes what it sees, which common rashes it looks like and when to see a doctor, and you get a skin care plan as a PDF. It does not diagnose. One check is $4.99.Add a photo

More in rash on GLP-1 medicines.

Frequently asked questions

Is skin sensitivity a side effect of Ozempic?+

It is a recognized effect. The Ozempic label lists dysesthesia, meaning altered skin sensations such as burning or tingling, among reports after approval. The label cannot give a frequency for those reports. If you feel it, tell the prescriber so other causes can be ruled out.

Does Mounjaro cause skin sensitivity away from the injection site?+

The Mounjaro label reports dysesthesia in 0.4% of people in each of its three dose groups in placebo-controlled trials, versus none on placebo, and does not tie it to the injection site. It is an altered skin sensation, usually with no visible rash.

What is allodynia?+

Allodynia is pain from something that does not normally hurt. A 2026 case series defines it as extreme sensitivity to touch or mild temperature change. In daily life that can mean a light touch, clothing or a shower.

Why does my skin hurt but there is no rash?+

Dysesthesia is a change in sensation, not a visible skin change, so the skin can look completely normal. The authors of one case series note that no mechanism has been identified. A doctor can check for other causes, such as shingles or nerve problems.

Does skin sensitivity from semaglutide go away?+

In the Wegovy label's higher-dose trials, among 288 people with dysesthesia, 18% had not reported recovering by the end of the trial, so most had. Case reports describe it clearing within weeks to months, some without any change to treatment. No one can give you a date, and what to do about the medicine is for the prescriber.

What helps burning or painful skin on Wegovy or Zepbound?+

We found no tested treatment for it. See the prescriber first, keep a symptom diary, and ask a pharmacist before using any pain reliever or product on the skin. Loose soft clothing and lukewarm showers only make days easier.

Is burning skin a sign of an allergic reaction?+

Burning alone is not on the Medication Guides' list of serious allergic reaction signs. Those are swelling of the face, lips, tongue or throat, trouble breathing or swallowing, severe rash or itching, fainting or dizziness, and a very rapid heartbeat. Any of them means 911.

Could burning skin on a GLP-1 medicine be shingles?+

It can be. The first signs of shingles can be a tingling or painful feeling in an area of skin before a blistering rash appears a few days later, on one side of the body. If your burning is in a band or patch on one side, see a doctor the same day.

Sources

  • Novo Nordisk. Wegovy (semaglutide) injection prescribing information and Medication Guide. DailyMed, label revised June 2026. DailyMed
  • Eli Lilly and Company. Zepbound (tirzepatide) prescribing information and Medication Guide. DailyMed, label revised September 2026. DailyMed
  • Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information and Medication Guide. DailyMed, label revised September 2026. DailyMed
  • Novo Nordisk. Ozempic (semaglutide) injection prescribing information and Medication Guide. DailyMed, label revised June 2026. DailyMed
  • Laroche ML, Géniaux H, Jardou M. Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review. European Journal of Clinical Pharmacology. 2026. PubMed 42168638
  • Stark J, Klass MJ, Owen L. Allodynia (skin tenderness) associated with semaglutide: a case series. American Journal of Health-System Pharmacy. 2025. PubMed 39862389
  • Ahern S. Allodynia and dysesthesia associated with semaglutide and tirzepatide. Cureus. 2025. PubMed 41210042
  • Chakrabarti MP, Han S, Campbell NM. Cutaneous allodynia associated with GLP-1RA tirzepatide for weight management: a case series. American Journal of Case Reports. 2026. PubMed 42101979
  • Elgindi D, Petronic-Rosic V. Glucagon-like peptide-1 receptor agonist-associated injection site and dermatologic reactions. Clinics in Dermatology. 2026. PubMed 42692277
  • National Health Service (UK). Shingles. nhs.uk, accessed October 2026. nhs.uk
  • National Health Service (UK). Peripheral neuropathy. nhs.uk, accessed October 2026. nhs.uk
Updated 2026-10-07
Medical review pending. A board-certified clinician is attached before publishing.

This article is for general education and is not medical advice. It does not replace a consultation with a qualified clinician. If a symptom worries you, see a doctor.